TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells.

British Journal of Cancer
Giuseppina CantarellaRenato Bernardini

Abstract

Tumour growth is tightly related to new blood vessel formation, tissue remodelling and invasiveness capacity. A number of tissular factors fuel the growth of glioblastoma multiforme, the most aggressive brain neoplasm. In fact, gene array analyses demonstrated that the proapoptotic cytokine tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) inhibited mRNA expression of VEGF, along with those of matrix metalloproteinase-2 (MMP-2), its inhibitor tissue inhibitor of matrix metalloproteinases-2 (TIMP-2), as well as the tumour invasiveness-related gene secreted protein acid rich in cysteine (SPARC) in different human glioblastoma cell lines. Particularly, VEGF mRNA and protein expression and release from glioblastoma cells were also inhibited by TRAIL. The latter also exerted antimitogenic effects on human umbilical vein endothelial cells (HUVECs). With the same cells, TRAIL inhibited new vessel formation in the in vitro matrigel model, as well as it exerted powerful inhibition of blood vessel formation induced by an angiogenic cocktail administered in subcutaneous pellets in vivo in the C57 mouse. Moreover, the expression of MMP-2, its inhibitor TIMP-2 and the tumour invasiveness-related protein SPARC were effectively...Continue Reading

References

Mar 29, 1995·International Journal of Cancer. Journal International Du Cancer·A AlbiniS De Flora
Feb 1, 1997·Endocrine Reviews·N Ferrara, T Davis-Smyth
Apr 17, 1997·Nature·W Risau
Jul 1, 1997·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·D QuaratinoA Venuti
Aug 26, 1998·The American Journal of Pathology·K LampertB Volk
Nov 26, 1999·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·S K ChintalaJ S Rao
Apr 27, 2000·American Journal of Physiology. Lung Cellular and Molecular Physiology·B R GochuicoA Fine
Jun 14, 2000·Clinical & Experimental Metastasis·Z KachraR Béliveau
Jun 22, 2000·International Journal of Cancer. Journal International Du Cancer·P VajkoczyS A Rempel
Oct 12, 2000·Pediatric Neurosurgery·D ZagzagG D Yancopoulos
Nov 22, 2001·Journal of Neuro-oncology·H L FillmoreW C Broaddus
Mar 29, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·N E SounniA Noel
Nov 29, 2002·Frontiers in Bioscience : a Journal and Virtual Library·Mitsutoshi NakadaJunkoh Yamashita
Jan 4, 2003·Journal of Neuro-oncology·William A Golembieski, Sandra A Rempel
Jun 5, 2003·Nature Medicine·Napoleone FerraraJennifer LeCouter
Jun 6, 2003·Cytokine & Growth Factor Reviews·Alexandru Almasan, Avi Ashkenazi
Jul 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jie Hui LiJordan S Pober
Mar 16, 2004·Cancer Treatment and Research·Till Acker, Karl H Plate
Jul 17, 2004·Neoplasia : an International Journal for Oncology Research·Paola SecchieroGiorgio Zauli
Sep 9, 2004·Frontiers in Bioscience : a Journal and Virtual Library·Shlomit Goldman, Eliezer Shalev
Feb 16, 2005·Apoptosis : an International Journal on Programmed Cell Death·V K PuduvalliA P Kyritsis
Nov 1, 1993·Trends in Cardiovascular Medicine·N Ferrara

❮ Previous
Next ❯

Citations

Apr 22, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Suizhao WangDina Lev
Oct 23, 2013·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Betül CelikLudwig G Strauss
Dec 6, 2011·Nature Materials·Jiangbing ZhouW Mark Saltzman
Apr 3, 2015·BioMed Research International·Paolo PerriPaola Secchiero
Dec 6, 2016·International Journal of Molecular Sciences·Siân P CartlandMary M Kavurma
Feb 1, 2017·Journal of Drug Targeting·Fathia Zaki El SharkawiLaila Ahmed Rashed
May 7, 2008·Cancer Metastasis Reviews·Osvaldo L PodhajcerAndrea S Llera
Jun 4, 2008·Folia Histochemica Et Cytobiologica·Ewa JablonskaLeszek Piotrowski
May 11, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ran AnAnnika Weigand
Jan 12, 2008·Cancer Immunology, Immunotherapy : CII·S H Beachy, E A Repasky
Feb 12, 2019·Scientific Reports·Carlotta SpanoMassimo Dominici
Jun 11, 2008·Cancer Metastasis Reviews·Osvaldo L PodhajcerAndrea S Llera
Apr 23, 2017·Oncotarget·Jiu-Ming ZouZuo-Hua Feng
Sep 16, 2017·Ocular Immunology and Inflammation·Ahmed M Abu El-AsrarGhislain Opdenakker
Nov 26, 2014·Stem Cells·Giulia GrisendiMassimo Dominici
May 1, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bin YanZuo-Hua Feng
Aug 14, 2018·Frontiers in Medicine·Adam T BraithwaiteAllan Lawrie
Jan 10, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ariane GrothIngrid Herr
Jun 25, 2021·Arteriosclerosis, Thrombosis, and Vascular Biology·Anne CornelissenAloke V Finn
Jul 24, 2021·Nutrition and Cancer·Afshin KaramiAmir Kiani
Jan 17, 2009·The American Journal of Pathology·Marjaneh RazmaraMark L Tykocinski

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
X-ray
electrophoresis
gene array
gene

Software Mentioned

GEArray analyser
Image Pro Plus
scanlyser

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.